Evidence map›Paper›PMID 38702654›Full record

ArticleBMC musculoskeletal disorders2024

Impact of surgical risk factors for non-union on lumbar spinal fusion outcomes using cellular bone allograft at 24-months follow-up.

Anthony Russo, Daniel K Park, Todd Lansford, Pierce Nunley, Timothy A Peppers, Joshua J Wind, Hamid Hassanzadeh, Joseph Sembrano, Jung Yoo, Jonathan Sales

Registry-linked trialAbstract read
In one paragraph

Article in BMC musculoskeletal disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02969616 (A Prospective, Post Market, Multi-center, Open Label, Non-Randomized Clinical Study of the Efficacy of Using Trinity ELITE in Lumbar Fusion Surgery), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02969616 unknown statusnot on this map

A Prospective, Post Market, Multi-center, Open Label, Non-Randomized Clinical Study of the Efficacy of Using Trinity ELITE in Lumbar Fusion Surgery

TypeobservationalSponsorOrthofix Inc.Ran2016 to 2022Enrolled300ConditionsDegenerative Disc DiseaseArmsTrinity Elite
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Anthony RussoYellowstone Orthopedic and Spine Institute, Billings Clinic Bozeman, 3905 Wellness Way, 4534 Apt A Perry Street, Bozeman, MT, USA. arusso@mtspinalsolutions.com.
Daniel K ParkBeaumont Hospital, 3601 W 13 Mile Rd, Royal Oak, MI, USA.
Todd LansfordSouth Carolina Sports Medicine, 9100 Medcom, N Charleston, SC, USA.
Pierce NunleySpine Institute of Lousiana, 1500 Line Ave, Shreveport, LA, USA.
Timothy A PeppersScripps Memorial Hospital Encinitas, 354 Santa Fe Drive, Encinitas, CA, USA.
Joshua J WindSibley Memorial Hospital, 5255 Loughboro Rd. NW, Washington, DC, USA.
Hamid HassanzadehJohn Hopkins Medicine, 6420 Rockledge Dr, Bethesda, MD, USA.
Joseph SembranoUniversity of Minnesota, 909 Fulton St SE, Minneapolis, MN, USA.
Jung YooOregon Health and Science University Hospital, 3303 S Bond Ave, Portland, OR, USA.
Jonathan SalesSummit Spine, 9155 SW Barnes Rd. 210, Portland, OR, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe current report investigates fusion rates and patient-reported outcomes following lumbar spinal surgery using cellular bone allograft (CBA) in patients with risk factors for non-union.

methodsA prospective, open label study was conducted in subjects undergoing lumbar spinal fusion with CBA (NCT02969616) to assess fusion success rates and patient-reported outcomes in subjects with risk factors for non-union. Subjects were categorized into low-risk (≤ 1 risk factors) and high-risk (> 1 risk factors) groups. Radiographic fusion status was evaluated by an independent review of dynamic radiographs and CT scans. Patient-reported outcome measures included quality of life (EQ-5D), Oswestry Disability Index (ODI) and Visual Analog Scales (VAS) for back and leg pain. Adverse event reporting was conducted throughout 24-months of follow-up.

resultsA total of 274 subjects were enrolled: 140 subjects (51.1%) were categorized into the high-risk group (> 1 risk factor) and 134 subjects (48.9%) into the low-risk group (≤ 1 risk factors). The overall mean age at screening was 58.8 years (SD 12.5) with a higher distribution of females (63.1%) than males (36.9%). No statistical difference in fusion rates were observed between the low-risk (90.0%) and high-risk (93.9%) groups (p > 0.05). A statistically significant improvement in patient-reported outcomes (EQ-5D, ODI and VAS) was observed at all time points (p < 0.05) in both low and high-risk groups. The low-risk group showed enhanced improvement at multiple timepoints in EQ-5D, ODI, VAS-Back pain and VAS-Leg pain scores compared to the high-risk group (p < 0.05). The number of AEs were similar among risk groups.

conclusionsThis study demonstrates high fusion rates following lumbar spinal surgery using CBA, regardless of associated risk factors. Patient reported outcomes and fusion rates were not adversely affected by risk factor profiles.

trial registrationNCT02969616 (21/11/2016).

Indexed as

Bone TransplantationLumbar VertebraePatient Reported Outcome MeasuresSpinal FusionAdultAgedAllograftsFemaleFollow-Up StudiesHumansMaleMiddle AgedPain MeasurementProspective StudiesQuality of LifeRisk FactorsArthrodesisCellular allograftLumbar fusionOperative risk factorsTrinity elite

Identifiers

PMID38702654
PMCPMC11067233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.